Nimrod Bin-Nun

Nimrod Bin-Nun is an experienced leader in the life sciences and healthcare sectors, serving as CEO and Co-Founder of RespirAI Medical since January 2022, where an AI-based platform is being developed to enhance management of chronic respiratory diseases. Bin-Nun also operates as a freelance consultant through Bin-Nun Life Sciences Ltd. and co-founded BNG Life Sciences Ltd., specializing in medical devices and healthcare technologies. Previous roles include co-founding Sparrow Cosmetics & Lifestyle, managing business development for Ella Therapeutics, and serving as CEO of DiagnosTear Ltd., which developed an innovative dry-eye diagnostic test. Bin-Nun held significant positions at BioLight Life Sciences Ltd. and Teva Pharmaceutical Industries Ltd., focusing on strategy, business development, and market expansion, supported by an MBA and BA from Tel Aviv University.